22:41 , Jan 19, 2017 |  BC Innovations  |  Finance

IMI branches out

The Innovative Medicines Initiative (IMI) is broadening its base in its latest call for proposals by bringing in funding partners from the non-profit sector. The new partners will add to the portfolio of projects backed...
07:00 , Sep 19, 2016 |  BC Week In Review  |  Company News

AITbiotech, Novogene deal

Beijing Novogene and AITbiotech formed JV NovogeneAIT Genomics Singapore to provide next-generation sequencing (NGS) and high-throughput screening services to companies in South Asia, using the HiSeq X Ten sequencing system from Illumina Inc. (NASDAQ:ILMN,...
07:00 , Jun 4, 2012 |  BC Week In Review  |  Company News

AITbiotech Pte. Ltd., Agency for Science, Technology and Research (A*STAR) sales and marketing update

A*STAR's Exploit Technologies Pte. Ltd. tech transfer arm granted AITbiotech commercialization rights in Asia and Europe to the H5N1 real-time reverse transcription polymerase chain reaction (RT-PCR) assay. A*STAR says the diagnostic detects all existing strains...
07:00 , Sep 27, 2010 |  BC Week In Review  |  Company News

Aitbiotech Pte. Ltd., Agency for Science, Technology and Research deal

Aitbiotech Pte. Ltd., Singapore   Agency for Science, Technology and Research (A*STAR), Singapore   Business: Diagnostic   A*STAR's Exploit Technologies Pte. Ltd. strategic marketing and commercialization arm granted undisclosed rights to Aitbiotech for three of the agency's diagnostics:...